Skip to content

Clinical trials

Completed Phase 2 Myeloproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Phase 2 Status: Completed Clear all

127 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20016
20026
20036
20049
20059
20068
20078
20083
20092
20101
20117
20125
20133
20141
20156
20162
20176
20184
20192
20201
20215
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed127

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center18
Case Comprehensive Cancer Center10
Memorial Sloan Kettering Cancer Center8
Incyte Corporation6
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5
City of Hope Medical Center4
H. Lee Moffitt Cancer Center and Research Institute4
M.D. Anderson Cancer Center4
Roswell Park Cancer Institute4
Masonic Cancer Center, University of Minnesota3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders127
Myelodysplastic Syndromes81
Leukemia, Myeloid, Acute65
Leukemia62
Precursor Cell Lymphoblastic Leukemia-Lymphoma56
Leukemia, Lymphocytic, Chronic, B-Cell51
Hodgkin Disease48
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative48
Leukemia, Myelomonocytic, Chronic48
Primary Myelofibrosis48

Trials

Showing 1 to 25 of 127. Each trial links to its page on Pharma Observatory.

27 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.